Hot Biotech Trades for Second-Half 2011

Description:

According to Adam Feuerstein, these biotech trades "encompass pending FDA drug approval decisions and clinical trial results -- all of which have the potential to produce significant stock-price volatility in the next six months." Read more here.

>>Also: 3 Funds' Best Stock Picks Ahead of Earnings

>>Also: 7 Best-Performing Dow Stocks

Most Viewed Portfolios

View All

Articles

5 Unusual-Volume Stocks Poised for Breakouts

10.23.14 | 09:04 AM

DELAFIELD, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track...

4 Stocks Spiking on Big Volume

10.23.14 | 09:04 AM

DELAFIELD, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter